| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.36T | 3.20T | 2.96T | 2.86T | 2.53T |
| Gross Profit | 1.37T | 1.30T | 1.19T | 1.14T | 1.03T |
| EBITDA | 522.58B | 493.72B | 426.74B | 415.29B | 362.70B |
| Net Income | 276.74B | 260.95B | 243.51B | 219.42B | 211.18B |
Balance Sheet | |||||
| Total Assets | 6.05T | 5.25T | 4.78T | 4.13T | 3.96T |
| Cash, Cash Equivalents and Short-Term Investments | 170.55B | 172.11B | 179.72B | 268.61B | 486.33B |
| Total Debt | 1.03T | 802.28B | 607.63B | 462.58B | 535.56B |
| Total Liabilities | 2.21T | 1.90T | 1.61T | 1.35T | 1.43T |
| Stockholders Equity | 3.84T | 3.35T | 3.17T | 2.76T | 2.50T |
Cash Flow | |||||
| Free Cash Flow | -111.03B | -74.63B | -56.77B | -113.02B | 158.03B |
| Operating Cash Flow | 410.56B | 428.16B | 407.94B | 210.45B | 323.93B |
| Investing Cash Flow | -554.60B | -541.95B | -527.42B | -323.23B | -153.54B |
| Financing Cash Flow | 120.25B | 108.88B | -462.00M | -123.69B | -105.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥959.21B | 13.85 | 7.77% | 3.16% | 1.93% | 25.12% | |
79 Outperform | ¥786.26B | 16.69 | 10.50% | 2.03% | 3.03% | 26.77% | |
75 Outperform | ¥4.00T | 14.47 | 7.81% | 2.07% | 5.04% | 5.98% | |
70 Outperform | ¥34.47B | 3.43 | ― | 4.37% | -2.63% | 635.00% | |
67 Neutral | ¥830.30B | 14.91 | 6.04% | 2.78% | 3.18% | 24.19% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥301.09B | 9.95 | -12.69% | 0.71% | -3.56% | ― |